SG11201807032PA - Compositions useful in the prevention and/or treatment of inflammation and pain - Google Patents

Compositions useful in the prevention and/or treatment of inflammation and pain

Info

Publication number
SG11201807032PA
SG11201807032PA SG11201807032PA SG11201807032PA SG11201807032PA SG 11201807032P A SG11201807032P A SG 11201807032PA SG 11201807032P A SG11201807032P A SG 11201807032PA SG 11201807032P A SG11201807032P A SG 11201807032PA SG 11201807032P A SG11201807032P A SG 11201807032PA
Authority
SG
Singapore
Prior art keywords
international
extract
pct
inflammation
pain
Prior art date
Application number
SG11201807032PA
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of SG11201807032PA publication Critical patent/SG11201807032PA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/758Zanthoxylum, e.g. pricklyash
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548Phosphates or phosphonates, e.g. bone-seeking
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -, Organization 11111111011110111010101111101011111011101011101110111110111011111101111011111 International Bureau ... ..... ..Yi j (10) International Publication Number (43) International Publication Date ..... ...r .....1 WO 2017/144411 Al 31 August 2017 (31.08.2017) WIPO I PCT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 36/758 (2006.01) A61K 36/28 (2006.01) kind A61K 36/9066 (2006.01) A61P 19/02 (2006.01) AO, A61K 36/9068 (2006.01) A61P 29/00 (2006.01) BZ, DO, of national protection available): AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DZ, EC, EE, EG, ES, FL GB, GD, GE, GH, GM, GT, (21) International Application Number: HN, PCT/EP2017/053787 KP, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, (22) International Filing Date: MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, 20 February 2017 (20.02.2017) NI, RU, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, (25) Filing Language: English TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, (26) Publication Language: English ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 102016000019244 kind 24 February 2016 (24.02.2016) IT GM, TZ, of regional protection available): ARIPO (BW, GH, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (71) Applicant: INDENA S.P.A. [IT/IT]; Viale Ortles, 12, TJ, 20139 Milano (IT). DK, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, (72) Inventor: BOMBARDELLI, Ezio; Via Gabetta, 13, LV, 27027 Groppello Cairoli (PV) (IT). SM, GW, KM, ML, MR, NE, SN, TD, TG). MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, (74) Agent: BERTUCCIO, Silvia; Bianchetti Bracco Minoja S.r.1., Via Plinio, 63, 20129 Milano (IT). Published: — with international search report (Art. 21(3)) 1-1 11 11 7r 7r 7r 11 IN 11 (54) Title: COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF INFLAMMATION AND PAIN 0 ei (57) : Disclosed are compositions comprising: a) an extract of Curcuma longa, curcumin or phospholipid-complexed eift ) curcumin; b) a lipophilic extract of Zingiber officinale; and c) a lipophilic extract obtained from plants containing isobutylamides of i9 polyunsaturated fatty acids selected from the group consisting of Echinacea spp. extract, Zanthoxylum spp. extract and Acmella ol- eracea (Spilanthes oleracea) extract.
SG11201807032PA 2016-02-24 2017-02-20 Compositions useful in the prevention and/or treatment of inflammation and pain SG11201807032PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2016A001030A ITUB20161030A1 (en) 2016-02-24 2016-02-24 USEFUL COMPOSITIONS IN PREVENTION AND / OR IN THE TREATMENT OF INFLAMMATION AND PAIN
PCT/EP2017/053787 WO2017144411A1 (en) 2016-02-24 2017-02-20 Compositions useful in the prevention and/or treatment of inflammation and pain

Publications (1)

Publication Number Publication Date
SG11201807032PA true SG11201807032PA (en) 2018-09-27

Family

ID=56027067

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201807032PA SG11201807032PA (en) 2016-02-24 2017-02-20 Compositions useful in the prevention and/or treatment of inflammation and pain

Country Status (20)

Country Link
US (1) US11534472B2 (en)
EP (1) EP3419641B1 (en)
JP (1) JP7111617B2 (en)
KR (1) KR20180113538A (en)
CN (1) CN108697751B (en)
AU (1) AU2017222166B2 (en)
BR (1) BR112018016965B1 (en)
CA (1) CA3015119A1 (en)
DK (1) DK3419641T3 (en)
ES (1) ES2913094T3 (en)
HU (1) HUE058915T2 (en)
IL (1) IL261240B (en)
IT (1) ITUB20161030A1 (en)
MX (1) MX2018010060A (en)
PL (1) PL3419641T3 (en)
PT (1) PT3419641T (en)
RU (1) RU2752320C2 (en)
SG (1) SG11201807032PA (en)
SI (1) SI3419641T1 (en)
WO (1) WO2017144411A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1031315A (en) 1988-09-13 1989-03-01 孙守连 Preparation for flavouring juice
ATE123947T1 (en) 1990-07-05 1995-07-15 Indena Spa ECHINACEA EXTRACTS, METHOD OF PREPARATION AND PREPARATIONS CONTAINING THEM.
ITMI981542A1 (en) 1998-07-07 2000-01-07 Indena Spa EXTRACTS OF ZANTHOXYLUM BUNGEANUM AND THEIR PHARMACEUTICAL AND COSMETIC FORMULATIONS
CN101249256A (en) 2008-04-11 2008-08-27 李庭华 Preparing method of medicament for curing severe rheumatic arthritis
IT1401141B1 (en) * 2010-07-26 2013-07-12 Indena Spa FORMULATIONS CONTAINING EXTRACTS OF ECHINACEA ANGUSTIFOLIA AND ZINGIBER OFFICINALE USEFUL IN THE REDUCTION OF INFLAMMATION AND PERIPHERAL PAIN
US9088471B1 (en) * 2014-02-19 2015-07-21 Qualcomm Incorporated Quadrature combining and adjusting
KR102350519B1 (en) * 2014-02-20 2022-01-14 인데나 에스.피.에이 Compositions containing extracts of Curcuma longa and Echinacea angustifolia which are useful to reduce peripheral inflammation and pain
CN105012901A (en) * 2014-12-02 2015-11-04 陈方标 Bone-infiltrating pain-eliminating liquid liniment for neck and waist
CN104758451A (en) * 2015-04-28 2015-07-08 童长虹 Traditional Chinese medicine composite for treating gout
CN104921053A (en) * 2015-07-06 2015-09-23 天宁香料(江苏)有限公司 Preparation method of chicken flavor essence seasoning
ITUA20164757A1 (en) * 2016-06-29 2017-12-29 Indena Spa USEFUL COMPOSITIONS IN THE PREVENTION AND / OR IN THE TREATMENT OF INFLAMMATION AND OSTEOARTICULAR PAIN AND PAPER DAMAGE

Also Published As

Publication number Publication date
PL3419641T3 (en) 2022-06-27
ITUB20161030A1 (en) 2017-08-24
RU2018130117A3 (en) 2020-05-12
CN108697751B (en) 2022-01-21
RU2752320C2 (en) 2021-07-26
DK3419641T3 (en) 2022-04-19
WO2017144411A1 (en) 2017-08-31
US11534472B2 (en) 2022-12-27
EP3419641A1 (en) 2019-01-02
RU2018130117A (en) 2020-03-25
BR112018016965A2 (en) 2019-01-08
JP2019506421A (en) 2019-03-07
JP7111617B2 (en) 2022-08-02
HUE058915T2 (en) 2022-09-28
AU2017222166A1 (en) 2018-09-06
EP3419641B1 (en) 2022-04-06
CN108697751A (en) 2018-10-23
AU2017222166B2 (en) 2023-11-09
KR20180113538A (en) 2018-10-16
US20210205388A1 (en) 2021-07-08
SI3419641T1 (en) 2022-06-30
IL261240A (en) 2018-10-31
ES2913094T3 (en) 2022-05-31
MX2018010060A (en) 2019-01-21
BR112018016965B1 (en) 2022-10-25
CA3015119A1 (en) 2017-08-31
PT3419641T (en) 2022-05-13
IL261240B (en) 2022-05-01

Similar Documents

Publication Publication Date Title
SG11201900975XA (en) Formulation for inhibiting formation of 5-ht 2b agonists and methods of using same
SG11201901996UA (en) Formulations of ( r)-2-amino-3-phenylpropyl carbamate
SG11201811432WA (en) Rna for cancer therapy
SG11201907034PA (en) Methods of treating influenza
SG11201806991XA (en) Insect repellent
SG11201809605PA (en) Compositions for and method of treating acid-base disorders
SG11201900554YA (en) Spiro-lactam nmda modulators and methods of using same
SG11201903061YA (en) Combination treatments comprising administration of imidazopyrazinones
SG11202000141WA (en) Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof
SG11201907604UA (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201809824VA (en) Pixel array medical systems, devices and methods
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201807963WA (en) Compositions useful in the prevention and/or treatment of disorders of the oral cavity, upper airways and esophagus
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201809341PA (en) Mobile robot
SG11201901438VA (en) Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
SG11201811680VA (en) Compositions useful in the prevention and/or treatment of osteoarticular inflammation and pain and cartilage damage
SG11201809594WA (en) Nicotine particles and compositions
SG11201805565YA (en) Systems and methods for collecting a species
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201901048VA (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
SG11201806127XA (en) Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate
SG11201900275QA (en) Alcoholic disinfectant with good skincare effect and high efficacy
SG11201805714YA (en) Surgical robotic devices and systems for use in performing minimally invasive and natural orifice transluminal endoscopic surgical actions